Therapeutics (TGTX) 2025 Earnings Outlook for Investors
TG Therapeutics faces a pivotal year as it closes 2025 with a tighter focus on its flagship therapeutics portfolio an...
Generating extra cash can help alleviate your debt burden. Explore various options to boost your income effectively.
20,698 articlesTG Therapeutics faces a pivotal year as it closes 2025 with a tighter focus on its flagship therapeutics portfolio an...
SentinelOne hit a $1 billion ARR milestone as revenue growth decelerated and operating margins improved, but investor...
Bank of America upgrades Oracle to Buy, signaling potential upside as AI-driven cloud demand and a massive backlog cr...
The SPDR Russell 1000 Yield Focus ETF nears a $125 price point, anchored by Johnson & Johnson and other blue-chip div...
As AI spending reshapes the cloud landscape, investors face a clear choice between Alphabet and MICROSOFT. This piece...
Micron investors are bracing for a pivotal June 24 earnings report. This guide explains the drivers, possible outcome...
Investors ask whether to buy Domino's stock before a major investor update. This guide breaks down the decision, back...
Oracle stock sinks to a fresh 52-week low as a rating downgrade raises capital-structure questions while AI ambitions...
A bitcoin miner is branching into AI infrastructure, and the market has taken notice. The plan to turn U.S. sites int...
Philip Morris International and British American Tobacco report 2025 results, revealing divergent paths in smoke-free...
Apple posted a record iPhone quarter and Meta pushed ad revenue higher, but each faces starkly different bets on AI a...
REZ steadies its footing as a mix of healthcare REITs and self-storage assets cushions exposure to a softening reside...